Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Júlia Pauli De Cól,
No information about this author
Enzo Pereira de Lima,
No information about this author
Fernanda Moris Pompeu
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(7), P. 3694 - 3694
Published: March 26, 2024
Metabolic-associated
fatty
liver
disease
(MAFLD)
includes
several
metabolic
dysfunctions
caused
by
dysregulation
in
the
brain–gut–liver
axis
and,
consequently,
increases
cardiovascular
risks
and
dysfunction.
In
MAFLD,
type
2
diabetes
mellitus,
obesity,
syndrome
are
frequently
present;
these
conditions
related
to
lipogenesis
systemic
inflammation.
This
study
aimed
review
connection
between
MAFLD.
The
inflammatory
process,
cellular
alterations
hepatocytes
stellate
cells,
hypercaloric
diet,
sedentarism
aggravate
prognosis
of
patients
with
Thus,
understand
modulation
physiopathology
it
is
necessary
include
organokines
involved
this
process
(adipokines,
myokines,
osteokines,
hepatokines)
their
clinical
relevance
project
future
perspectives
condition
bring
light
new
possibilities
therapeutic
approaches.
Adipokines
responsible
for
activation
distinct
signaling
different
tissues,
such
as
insulin
pro-inflammatory
cytokines,
which
important
balancing
substances
avoid
MAFLD
its
progression.
Myokines
improve
quantity
quality
adipose
contributing
avoiding
development
Finally,
hepatokines
decisive
improving
or
not
progression
through
regulation
anti-inflammatory
organokines.
Language: Английский
Neural Networks and Chemical Messengers: Insights into Tobacco Addiction
Jieping Sun,
No information about this author
Qingqing Lv,
No information about this author
Jinghan Dang
No information about this author
et al.
Brain Topography,
Journal Year:
2025,
Volume and Issue:
38(4)
Published: May 13, 2025
Language: Английский
Physico-Chemical Characterization and Initial Evaluation of Carboxymethyl Chitosan–Hyaluronan Hydrocolloid Systems with Insulin Intended for Intranasal Administration
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(19), P. 10452 - 10452
Published: Sept. 27, 2024
The
nasal
route
of
administration
can
bypass
the
blood-brain
barrier
in
order
to
obtain
a
higher
concentration
brain,
thus
offering
feasible
alternative
for
diseases
associated
with
central
nervous
system.
advantages
intranasal
and
potential
favorable
therapeutic
effects
intranasally
administered
insulin
led
formulation
carboxymethyl
chitosan
(CMC)
sodium
hyaluronate
(NaHA)
hydrocolloidal
systems
administration,
targeting
nose-to-brain
delivery
initial
assessment
these
systems.
influence
variables
on
response
parameters
defined
as
surface
properties,
rheology,
vitro
release
were
analyzed
using
experimental
design
statistical
programs
(Modde
Minitab
software).
recorded
good
wetting
adhesion
capacity,
allowing
spread
mucosa.
samples
had
pseudoplastic
flow
rapid
was
according
our
objective.
According
physico-chemical
characterization
preliminary
assessment,
formulations
are
appropriate
mucosa,
but
further
studies
necessary
demonstrate
beneficial
actions
safety
insulin.
Language: Английский